Editas Medicine, Inc.EDITNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+19.6%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
+19.6%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202532.49%
2024-54.74%
202330.49%
2022-14.51%
2021-65.98%
202013.29%
2019-21.64%
20188.62%
2017-23.81%
2016-33.31%